Amyloidogenic sequences in native protein structures

Numerous short peptides have been shown to form β‐sheet amyloid aggregates in vitro. Proteins that contain such sequences are likely to be problematic for a cell, due to their potential to aggregate into toxic structures. We investigated the structures of 30 proteins containing 45 sequences known to form amyloid, to see how the proteins cope with the presence of these potentially toxic sequences, studying secondary structure, hydrogen‐bonding, solvent accessible surface area and hydrophobicity. We identified two mechanisms by which proteins avoid aggregation: Firstly, amyloidogenic sequences are often found within helices, despite their inherent preference to form β structure. Helices may offer a selective advantage, since in order to form amyloid the sequence will presumably have to first unfold and then refold into a β structure. Secondly, amyloidogenic sequences that are found in β structure are usually buried within the protein. Surface exposed amyloidogenic sequences are not tolerated in strands, presumably because they lead to protein aggregation via assembly of the amyloidogenic regions. The use of α‐helices, where amyloidogenic sequences are forced into helix, despite their intrinsic preference for β structure, is thus a widespread mechanism to avoid protein aggregation.

[1]  Janet M. Thornton,et al.  PDBsum more: new summaries and analyses of the known 3D structures of proteins and nucleic acids , 2004, Nucleic Acids Res..

[2]  C. Dobson,et al.  Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases , 2002, Nature.

[3]  Atanas V Koulov,et al.  Functional amyloid--from bacteria to humans. , 2007, Trends in biochemical sciences.

[4]  Francesc X. Avilés,et al.  AGGRESCAN: a server for the prediction and evaluation of "hot spots" of aggregation in polypeptides , 2007, BMC Bioinform..

[5]  I D Campbell,et al.  Amyloid fibril formation by an SH3 domain. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[6]  L. Serrano,et al.  Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins , 2004, Nature Biotechnology.

[7]  M. Hecht,et al.  Nature disfavors sequences of alternating polar and non-polar amino acids: implications for amyloidogenesis. , 2000, Journal of molecular biology.

[8]  Robert G Griffin,et al.  Molecular conformation of a peptide fragment of transthyretin in an amyloid fibril , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[9]  B. Ghetti,et al.  Synthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[10]  R. Leapman,et al.  Amyloid fibril formation by A beta 16-22, a seven-residue fragment of the Alzheimer's beta-amyloid peptide, and structural characterization by solid state NMR. , 2000, Biochemistry.

[11]  K. Iwata,et al.  3D structure of amyloid protofilaments of β2-microglobulin fragment probed by solid-state NMR , 2006, Proceedings of the National Academy of Sciences.

[12]  J. M. Scholtz,et al.  The role of protein stability, solubility, and net charge in amyloid fibril formation , 2003, Protein science : a publication of the Protein Society.

[13]  E. M. Jones,et al.  Role of N-terminal Familial Mutations in Prion Protein Fibrillization and Prion Amyloid Propagation in Vitro*♦ , 2006, Journal of Biological Chemistry.

[14]  D. Selkoe,et al.  Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.

[15]  C. Dobson,et al.  High-resolution molecular structure of a peptide in an amyloid fibril determined by magic angle spinning NMR spectroscopy. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[16]  M. L. Jones,et al.  PDBsum: a Web-based database of summaries and analyses of all PDB structures. , 1997, Trends in biochemical sciences.

[17]  Sharon Gilead,et al.  Identification and characterization of a novel molecular-recognition and self-assembly domain within the islet amyloid polypeptide. , 2002, Journal of molecular biology.

[18]  J. Kelly,et al.  Amyloid as a natural product , 2003, The Journal of cell biology.

[19]  Michele Vendruscolo,et al.  Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases. , 2005, Journal of molecular biology.

[20]  J. Bernhagen,et al.  Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties. , 2000, Journal of molecular biology.

[21]  J. Hoh,et al.  Amyloid-β Protofibrils Differ from Amyloid-β Aggregates Induced in Dilute Hexafluoroisopropanol in Stability and Morphology* , 2005, Journal of Biological Chemistry.

[22]  Salvador Ventura,et al.  Prediction of "hot spots" of aggregation in disease-linked polypeptides , 2005, BMC Structural Biology.

[23]  N. Watanabe,et al.  Identification of multiple amyloidogenic sequences in laminin-1. , 2007, Biochemistry.

[24]  David Eisenberg,et al.  Atomic structure of the cross‐β spine of islet amyloid polypeptide (amylin) , 2008, Protein science : a publication of the Protein Society.

[25]  E. Gazit Mechanisms of amyloid fibril self‐assembly and inhibition , 2005, The FEBS journal.

[26]  C. Dobson,et al.  Protein misfolding, functional amyloid, and human disease. , 2006, Annual review of biochemistry.

[27]  Andreas Hoenger,et al.  De novo designed peptide-based amyloid fibrils , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Mireille Dumoulin,et al.  Identification of the core structure of lysozyme amyloid fibrils by proteolysis. , 2006, Journal of molecular biology.

[29]  J. Richardson,et al.  Natural β-sheet proteins use negative design to avoid edge-to-edge aggregation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Maria Teresa Alvarez-Martinez,et al.  The role of the 132–160 region in prion protein conformational transitions , 2005, Protein science : a publication of the Protein Society.

[31]  Michele Vendruscolo,et al.  Prediction of local structural stabilities of proteins from their amino acid sequences. , 2007, Structure.

[32]  J Q Trojanowski,et al.  A Hydrophobic Stretch of 12 Amino Acid Residues in the Middle of α-Synuclein Is Essential for Filament Assembly* , 2001, The Journal of Biological Chemistry.

[33]  A. Esteras-Chopo,et al.  Design of model systems for amyloid formation: lessons for prediction and inhibition. , 2005, Current opinion in structural biology.

[34]  Heather T. McFarlane,et al.  Atomic structures of amyloid cross-β spines reveal varied steric zippers , 2007, Nature.

[35]  Fabrizio Chiti,et al.  Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[36]  D. Kirschner,et al.  X-Ray fiber and powder diffraction of PrP prion peptides. , 2006, Advances in protein chemistry.

[37]  J. Richardson,et al.  De novo design, expression, and characterization of Felix: a four-helix bundle protein of native-like sequence. , 1990, Science.

[38]  Christopher M. Dobson,et al.  Kinetic partitioning of protein folding and aggregation , 2002, Nature Structural Biology.

[39]  M. Baumann,et al.  Amphoterin includes a sequence motif which is homologous to the Alzheimer's beta-amyloid peptide (Abeta), forms amyloid fibrils in vitro, and binds avidly to Abeta. , 2001, Biochemistry.

[40]  D. Otzen,et al.  Designed protein tetramer zipped together with a hydrophobic Alzheimer homology: a structural clue to amyloid assembly. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Susan Jones,et al.  Amyloid-forming peptides from beta2-microglobulin-Insights into the mechanism of fibril formation in vitro. , 2003, Journal of molecular biology.

[42]  T. Sutherland,et al.  Insect silk: one name, many materials. , 2010, Annual review of entomology.

[43]  D. Baker,et al.  The 3D profile method for identifying fibril-forming segments of proteins. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Christopher M Dobson,et al.  Myoglobin forms amyloid fibrils by association of unfolded polypeptide segments , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Andreas Hoenger,et al.  Amyloid fibril formation propensity is inherent into the hexapeptide tandemly repeating sequence of the central domain of silkmoth chorion proteins of the A-family. , 2006, Journal of structural biology.

[46]  Niccolò Taddei,et al.  Assessing the role of aromatic residues in the amyloid aggregation of human muscle acylphosphatase , 2006, Protein science : a publication of the Protein Society.

[47]  A. Doig,et al.  The aggregation and membrane-binding properties of an α-synuclein peptide fragment , 2004 .

[48]  Ying Xu,et al.  Mapping abeta amyloid fibril secondary structure using scanning proline mutagenesis. , 2004, Journal of molecular biology.

[49]  F. Vollrath,et al.  Amyloidogenic nature of spider silk. , 2002, European journal of biochemistry.

[50]  K. Sletten,et al.  Prolactin-derived amyloid in the aging pituitary gland. , 1997, The American journal of pathology.

[51]  H. Kleinman,et al.  A synthetic peptide containing the IKVAV sequence from the A chain of laminin mediates cell attachment, migration, and neurite outgrowth. , 1989, The Journal of biological chemistry.

[52]  T. Sutherland,et al.  Fifty years later: the sequence, structure and function of lacewing cross-beta silk. , 2009, Journal of structural biology.

[53]  Fabrizio Chiti,et al.  Prevention of amyloid‐like aggregation as a driving force of protein evolution , 2007, EMBO reports.

[54]  P. Argos,et al.  Knowledge‐based protein secondary structure assignment , 1995, Proteins.

[55]  L. Tjernberg,et al.  Medin: an integral fragment of aortic smooth muscle cell-produced lactadherin forms the most common human amyloid. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[56]  Y. Kallberg,et al.  Prediction of Amyloid Fibril-forming Proteins* , 2001, The Journal of Biological Chemistry.

[57]  Meital Reches,et al.  Amyloid Fibril Formation by Pentapeptide and Tetrapeptide Fragments of Human Calcitonin* , 2002, The Journal of Biological Chemistry.

[58]  R. Giraldo Defined DNA sequences promote the assembly of a bacterial protein into distinct amyloid nanostructures , 2007, Proceedings of the National Academy of Sciences.

[59]  C. Dobson Protein misfolding, evolution and disease. , 1999, Trends in biochemical sciences.

[60]  Michele Vendruscolo,et al.  Prediction of the absolute aggregation rates of amyloidogenic polypeptide chains. , 2004, Journal of molecular biology.

[61]  Guoli Wang,et al.  PISCES: a protein sequence culling server , 2003, Bioinform..

[62]  R. Leapman,et al.  A structural model for Alzheimer's β-amyloid fibrils based on experimental constraints from solid state NMR , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[63]  C M Dobson,et al.  Designing conditions for in vitro formation of amyloid protofilaments and fibrils. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[64]  L. Serrano,et al.  Protein aggregation and amyloidosis: confusion of the kinds? , 2006, Current opinion in structural biology.

[65]  A. D'Ursi,et al.  Solution structure of the Alzheimer amyloid beta-peptide (1-42) in an apolar microenvironment. Similarity with a virus fusion domain. , 2002, European journal of biochemistry.

[66]  C. Dobson,et al.  Rationalization of the effects of mutations on peptide andprotein aggregation rates , 2003, Nature.

[67]  Amedeo Caflisch,et al.  Prediction of aggregation rate and aggregation‐prone segments in polypeptide sequences , 2005, Protein science : a publication of the Protein Society.

[68]  C. Dobson Protein folding and misfolding , 2003, Nature.

[69]  Y. Kallberg,et al.  Stabilization of discordant helices in amyloid fibril‐forming proteins , 2004, Protein science : a publication of the Protein Society.

[70]  Atanas V Koulov,et al.  Functional Amyloid Formation within Mammalian Tissue , 2005, PLoS biology.

[71]  Christopher M. Dobson,et al.  Prefibrillar Amyloid Aggregates Could Be Generic Toxins in Higher Organisms , 2006, The Journal of Neuroscience.

[72]  N. Guex,et al.  SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling , 1997, Electrophoresis.

[73]  V. Uversky,et al.  Conformational constraints for amyloid fibrillation: the importance of being unfolded. , 2004, Biochimica et biophysica acta.

[74]  C. Maury,et al.  Creation of amyloid fibrils from mutant Asn187 gelsolin peptides. , 1992, Biochemical and biophysical research communications.

[75]  Meital Reches,et al.  Amyloidogenic hexapeptide fragment of medin: homology to functional islet amyloid polypeptide fragments , 2004, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[76]  David Eisenberg,et al.  Atomic structures of amyloid cross-beta spines reveal varied steric zippers. , 2007, Nature.

[77]  L. Tjernberg,et al.  Unwinding fibril formation of medin, the peptide of the most common form of human amyloid. , 2007, Biochemical and biophysical research communications.

[78]  C. Dobson,et al.  Stimulation and inhibition of fibril formation by a peptide in the presence of different concentrations of SDS , 2002, FEBS letters.

[79]  R. Cappai,et al.  Amyloidogenicity and neurotoxicity of peptides corresponding to the helical regions of PrPC , 2000, Journal of neuroscience research.

[80]  C. Dobson,et al.  Formation of amyloid fibrils by peptides derived from the bacterial cold shock protein CspB , 1999, Protein science : a publication of the Protein Society.

[81]  C. Dobson,et al.  Competition between folding, native-state dimerisation and amyloid aggregation in beta-lactoglobulin. , 2009, Journal of molecular biology.

[82]  M. Hecht,et al.  Rationally designed mutations convert de novo amyloid-like fibrils into monomeric β-sheet proteins , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[83]  D. Thirumalai,et al.  Emerging ideas on the molecular basis of protein and peptide aggregation. , 2003, Current opinion in structural biology.

[84]  Peter Chien,et al.  Emerging principles of conformation-based prion inheritance. , 2004, Annual review of biochemistry.

[85]  G. Irvine,et al.  Aggregation and neurotoxicity of α-synuclein and related peptides , 2001 .

[86]  Ruth Nussinov,et al.  A comparative study of amyloid fibril formation by residues 15-19 of the human calcitonin hormone: a single beta-sheet model with a small hydrophobic core. , 2005, Journal of molecular biology.

[87]  A. Doig,et al.  Design of an N-methylated peptide inhibitor of alpha-synuclein aggregation guided by solid-state NMR. , 2008, Journal of the American Chemical Society.

[88]  R. Leapman,et al.  Amyloid Fibril Formation by Aβ16-22, a Seven-Residue Fragment of the Alzheimer's β-Amyloid Peptide, and Structural Characterization by Solid State NMR† , 2000 .

[89]  David Eisenberg,et al.  A systematic screen of β2-microglobulin and insulin for amyloid-like segments , 2006 .

[90]  D. Neill,et al.  Aggregates from mutant and wild‐type α‐synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of β‐sheet and amyloid‐like filaments , 1998, FEBS letters.

[91]  Fabrizio Chiti,et al.  Investigating the Effects of Mutations on Protein Aggregation in the Cell* , 2005, Journal of Biological Chemistry.

[92]  H. Kleinman,et al.  Ile‐Lys‐Val‐Ala‐Val (IKVAV)‐containing laminin α1 chain peptides form amyloid‐like fibrils , 2002, FEBS letters.

[93]  C. Dobson,et al.  Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution , 2003, Journal of Molecular Medicine.

[94]  C. Dobson,et al.  Biophysical studies of the development of amyloid fibrils from a peptide fragment of cold shock protein B. , 2000, European journal of biochemistry.

[95]  R. Tycko Progress towards a molecular-level structural understanding of amyloid fibrils. , 2004, Current opinion in structural biology.

[96]  L. Serpell,et al.  Common core structure of amyloid fibrils by synchrotron X-ray diffraction. , 1997, Journal of molecular biology.

[97]  J. Johansson Molecular determinants for amyloid fibril formation: lessons from lung surfactant protein C. , 2003, Swiss medical weekly.

[98]  David S. Wishart,et al.  VADAR: a web server for quantitative evaluation of protein structure quality , 2003, Nucleic Acids Res..

[99]  R. Jayakumar,et al.  Conformational polymorphism of the amyloidogenic peptide homologous to residues 113-127 of the prion protein. , 2003, Biophysical journal.

[100]  A. Huang,et al.  Identification of an amyloidogenic region on keratoepithelin via synthetic peptides , 2007, FEBS letters.

[101]  Louise C Serpell,et al.  Structures for amyloid fibrils , 2005, The FEBS journal.

[102]  C. Dobson,et al.  In vitro characterization of lactoferrin aggregation and amyloid formation. , 2003, Biochemistry.

[103]  Salvador Ventura,et al.  Short amino acid stretches can mediate amyloid formation in globular proteins: the Src homology 3 (SH3) case. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[104]  Amedeo Caflisch,et al.  Computational models for the prediction of polypeptide aggregation propensity. , 2006, Current opinion in chemical biology.

[105]  J. King,et al.  Frequencies of hydrophobic and hydrophilic runs and alternations in proteins of known structure , 2006, Protein science : a publication of the Protein Society.

[106]  R. Tycko,et al.  Molecular structure of amyloid fibrils: insights from solid-state NMR , 2006, Quarterly Reviews of Biophysics.

[107]  Michael H. Hecht,et al.  Generic hydrophobic residues are sufficient to promote aggregation of the Alzheimer's Aβ42 peptide , 2006, Proceedings of the National Academy of Sciences.

[108]  D. Kirschner,et al.  The Formation of Straight and Twisted Filaments from Short Tau Peptides* , 2004, Journal of Biological Chemistry.

[109]  Angelo Fontana,et al.  Amyloid fibril formation and disaggregation of fragment 1-29 of apomyoglobin: insights into the effect of pH on protein fibrillogenesis. , 2007, Journal of molecular biology.

[110]  Ehud Gazit,et al.  Analysis of the Minimal Amyloid-forming Fragment of the Islet Amyloid Polypeptide , 2001, The Journal of Biological Chemistry.

[111]  L. Serrano,et al.  A comparative study of the relationship between protein structure and beta-aggregation in globular and intrinsically disordered proteins. , 2004, Journal of molecular biology.

[112]  J. Wade,et al.  A structural core within apolipoprotein C-II amyloid fibrils identified using hydrogen exchange and proteolysis. , 2007, Journal of molecular biology.